Targeting of human Tmolt4 leukemic type II IMP dehydrogenase by cyclic imide related derivatives.
Saved in:
| Title: | Targeting of human Tmolt4 leukemic type II IMP dehydrogenase by cyclic imide related derivatives. |
|---|---|
| Authors: | Hall IH; Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599-7360, USA. iris_hall@unc.edu, Barnes BJ, Ward ES, Wheaton JR, Shaffer KA, Cho SE, Warren AE |
| Source: | Archiv der Pharmazie [Arch Pharm (Weinheim)] 2001 Jul; Vol. 334 (7), pp. 229-34. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-VCH Verlag GmbH & Co. KGaA Country of Publication: Germany NLM ID: 0330167 Publication Model: Print Cited Medium: Print ISSN: 0365-6233 (Print) Linking ISSN: 03656233 NLM ISO Abbreviation: Arch Pharm (Weinheim) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
